Will TGA have to consider another nasal spray trial?, page-2

First 2 Last

Share
Profile

Follow
Joelsmith2452

2,392 Posts.

385

10/06/25

10:36

Post #: 79374241
Share

Originally posted by Starlink: ↑

https://www.frontiersin.org/journals/medicine/articles/10.3389/fmed.2025.1565069/full

Today FRE has announced this successful ph3 trial of Nasodine nasal spray. Like Starpharma SPL7013 the claim is common cold treatment / prevention. TGA hasn’t approved any respiratory virus nasal sprays since before the pandemic but did approve ARTG for EXPORT of Nasodine which is made in Laverton in mid 2020. FRE was taking TGA to the AAT but high legal costs caused them to withdraw the action.
Wondering if although building up international market, a renewed effort to enter Nasodine in ARTG for Australian pharmacy sales will open an opportunity for VIRALEZE™ to be registered based on the independant study in the UK NHS Hospital funded by UK Regulator MHRA and peer reviewed in PHARMACEUTICALS peer reviewed paper Sept 2024 which strangely the delegate in the Sched 2 decision re Astodrimer sodium as nasal spray May 2024 refused to acknowledge the UK clinical study inferring it was still on going research when the preprint had been given to the TGA before decision as evidenced in TGA FOI

With few vaccinations provided free by the govt, it seems the main argument about people using effective nasal sprays might avoid vaccinations is DEAD now and freedom to spray our noses regularly with proven products needs revisiting

Expand

So Nasodine completes a Ph3 trial and you think that this will open the door for VIRALEZE in Australia somehow???

VIRALEZE has completed no Ph3 trials and the one trial that was undertaken in the UK FAILED to meet its end points......

This horse is done and dusted, please stop flogging it.......

SPL Price at posting: 9.3¢ Sentiment: Hold Disclosure: Held
2 Upvote

1 Great analysis

Reply

Top Stories

VBX Ltd jumps 15% on ASX debut as newest Oz bauxite player

PH2

Iran, nuclear energy, oil – a revival for hydrogen! Nel ASA, Pure Hydrogen, Plug Power, and Oklo

Tuesday's HotCopper trends: Meeka trading halt, MTM's Caldeira collab | June 17, 2025

DYL

Much-shorted Oz Uranium stocks enjoying big week – and big price jumps

Listen: HotCopper Wire Podcast 013 - They changed the IPO rules (and that's a good thing)

First 2 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 8.9¢		Change -0.002(2.20%)		Mkt cap ! $37.22M

Open	High	Low	Value	Volume
9.0¢	9.1¢	8.9¢	$18.03K	200.6K

Buyers (Bids)

No.	Vol.	Price($)
2	62927	8.9¢

Sellers (Offers)

Price($)	Vol.	No.
9.1¢	73652	3

View Market Depth

No.	Vol.	Price($)
2	62927	0.089
3	242958	0.088
2	185167	0.087
1	100000	0.086
1	10000	0.085

Price($)	Vol.	No.
0.091	73652	3
0.092	8036	2
0.093	14000	2
0.094	27699	4
0.095	152811	7

Last trade - 13.33pm 17/06/2025 (20 minute delay)

SPL (ASX) Chart

Will TGA have to consider another nasal spray trial?, page-2

VBX Ltd jumps 15% on ASX debut as newest Oz bauxite player

Iran, nuclear energy, oil – a revival for hydrogen! Nel ASA, Pure Hydrogen, Plug Power, and Oklo

Tuesday's HotCopper trends: Meeka trading halt, MTM's Caldeira collab | June 17, 2025

Much-shorted Oz Uranium stocks enjoying big week – and big price jumps

Listen: HotCopper Wire Podcast 013 - They changed the IPO rules (and that's a good thing)

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Will TGA have to consider another nasal spray trial?, page-2

Top Stories

VBX Ltd jumps 15% on ASX debut as newest Oz bauxite player

Iran, nuclear energy, oil – a revival for hydrogen! Nel ASA, Pure Hydrogen, Plug Power, and Oklo

Tuesday's HotCopper trends: Meeka trading halt, MTM's Caldeira collab | June 17, 2025

Much-shorted Oz Uranium stocks enjoying big week – and big price jumps

Listen: HotCopper Wire Podcast 013 - They changed the IPO rules (and that's a good thing)

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News